All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Auris Medical Holding AG brought the long-overlooked indication of tinnitus to the fore with word that enrollment will continue in its phase III trial testing AM-101 against the disorder, since the pre-specified futility threshold was not reached.